IL2 and breast carcinoma: A recent study reported that conjugation of IL-2-independent NK-92MI cells with trastuzumab by α(1,3)-fucosyltransferase activity elicited cytotoxicity to breast cancer BT-474 cells at an E:T ratio of 5:1 [39].